Our next guest’s company became an SC Launch member company in 2019, receiving a $25,000 academic startup grant. Three years later, they became an SC Launch portfolio company with a $200,000 investment. And all because of treatments they are developing to address vision loss. Mike Switzer interviews Michael Voevodsky, president and CEO of MitoChem Therapeutics in Charleston, SC.
Lowcountry company developing vision loss treatments
